Mauvieux L, Herbrecht R, Eischen A, Galoisy AC, Rolland D, Gervais C, Mayeur-Rousse C, Hueber-Bonnot S, Nicolae A, Fornecker LM, Goetsch T, Severac F, Bizoï R, Fabacher T, Miguet L

Blood Adv. 2025 11 25;9(22):5880-5887

Renin-Angiotensin System Drives Leukemia Progression by Reprogramming the Niche.

Guffroy B, Miguet L, Lioure B, Freund JN, Tavian M

Discov Med. 2025 02;37(193):409-410

[Acute myeloid leukemia with mutated RUNX1 at the university hospitals of Strasbourg].

Panaget B, Mauvieux L, Miguet L, Fornecker LM, Lioure B, Ledoux MP, Rolland D, Mayeur-Rousse C

Ann Biol Clin (Paris). 2024 08 30;82(3):266-280

TLRs1-10 Protein Expression in Circulating Human White Blood Cells during Bacterial and COVID-19 Infections.

Chomel L, Vogt M, Demiselle J, Le Borgne P, Tschirhart M, Morandeau V, Merdji H, Miguet L, Helms J, Meziani F, Mauvieux L

J Innate Immun. 2024 03 8;:

Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells.

Mayeur S, Molitor A, Miguet L, Rigolot L, Naegely L, Stemmelen T, Meyer S, Toussaint E, Vallat L, Eischen A, Chenard MP, Tavian M, Bahram S, Carapito R, Nicolae A

Blood Cancer J. 2023 08 9;13(1):118

Morpho-functional analysis of patient-derived xenografts reveals differential impact of gastric cancer and chemotherapy on the tumor ecosystem, affecting immune check point, metabolism, and sarcopenia.

Venkatasamy A, Guerin E, Reichardt W, Devignot V, Chenard MP, Miguet L, Romain B, Jung AC, Gross I, Gaiddon C, Mellitzer G

Gastric Cancer. 2022 12 19;:

Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group.

Fournier E, Heiblig M, Lespinasse C, Flandrin-Gresta P, Geay A, Miguet L, Fenwarth L, Vallat L, Soubeyrand B, Marceau-Renaut A, Plesa A, Preudhomme C, Sujobert P, Hayette S, Duployez N, Huet S

Leukemia. 2022 Mar 7;:

Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies.

Koeppel F, Muller E, Harlé A, Guien C, Sujobert P, Trabelsi Grati O, Kosmider O, Miguet L, Mauvieux L, Cayre A, Salgado D, Preudhomme C, Karayan-Tapon L, Tachon G, Coulet F, Lespagnol A, Beroud C, Leroy K, Rouleau E, Soubeyran I

Eur J Cancer. 2021 Oct 23;159:1-15

Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia.

Schleiss C, Carapito R, Fornecker LM, Muller L, Paul N, Tahar O, Pichot A, Tavian M, Nicolae A, Miguet L, Mauvieux L, Herbrecht R, Cianferani S, Freund JN, Carapito C, Maumy-Bertrand M, Bahram S, Bertrand F, Vallat L

Leukemia. 2021 Apr 8;:

Large deletions of the 5' region of IKZF1 lead to haploinsufficiency in B-cell precursor acute lymphoblastic leukaemia.

Morel G, Deau MC, Simand C, Caye-Eude A, Arfeuille C, Ittel A, Miguet L, Mauvieux L, Herbrecht R, Paillard C, Strullu M, Cavé H, Chan S, Kastner P, Heizmann B

Br. J. Haematol.. 2019 May 30;:

BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo.

Schleiss C, Ilias W, Tahar O, Güler Y, Miguet L, Mayeur-Rousse C, Mauvieux L, Fornecker LM, Toussaint E, Herbrecht R, Bertrand F, Maumy-Bertrand M, Martin T, Fournel S, Georgel P, Bahram S, Vallat L

Sci Rep. 2019 Jan 24;9(1):701

Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

Mauvieux L, Miguet L, Fornecker L

N. Engl. J. Med.. 2018 Jun 21;378(25):2442-3

Four genetic lymphoma-specific events (MYC, BCL2, BCL6 and CCND1) identified in a high grade B lymphoma case.

Ittel A, Hélias C, Wissler MP, Toussaint E, Miguet L, Chenard MP, Monier L, Gervais C, Mauvieux L

Blood Cancer J. 2015 Dec;5:e374

CD180 expression in B-cell lymphomas: A multicenter GEIL study.

Mayeur-Rousse C, Guy J, Miguet L, Bouyer S, Genevieve F, Robillard N, Solly F, Maar A, Bene MC, Mauvieux L

Cytometry B Clin Cytom. 2015 Sep 18

Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas.

Miguet L, Lennon S, Baseggio L, Traverse-Glehen A, Berger F, Perrusson N, Chenard MP, Galoisy AC, Eischen A, Mayeur-Rousse C, Maar A, Fornecker L, Herbrecht R, Felman P, Van Dorsselaer A, Carapito C, Cianférani S, Mauvieux L

Leukemia. 2013 Aug;27(8):1748-50

Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.

Miguet L, Bechade G, Fornecker L, Zink E, Felden C, Gervais C, Herbrecht R, van Dorsselaer A, Mauvieux L, Sanglier-Cianferani S

J Proteome Res. 2009 Jul;8(7):3346-54.

Microparticles: a new tool for plasma membrane sub-cellular proteomic.

Miguet L, Sanglier S, Schaeffer C, Potier N, Mauvieux L, Van Dorsselaer A

Subcell. Biochem.. 2007 ;43:21-34

Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.

Miguet L, Bogumil R, Decloquement P, Herbrecht R, Potier N, Mauvieux L, Van Dorsselaer A

J Proteome Res. 2006 Sep;5(9):2258-69.

Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.

Miguet L, Pacaud K, Felden C, Hugel B, Martinez MC, Freyssinet JM, Herbrecht R, Potier N, van Dorsselaer A, Mauvieux L

Proteomics. 2006 Jan;6(1):153-71.

NIR is a novel INHAT repressor that modulates the transcriptional activity of p53.

Hublitz P, Kunowska N, Mayer UP, Muller JM, Heyne K, Yin N, Fritzsche C, Poli C, Miguet L, Schupp IW, van Grunsven LA, Potiers N, van Dorsselaer A, Metzger E, Roemer K, Schule R

Genes Dev. 2005 Dec 1;19(23):2912-24.